DXB Ann: DMX-700 Study Shows Significant 80% Reduction in Lung Injury - 4th Jul 2022, 8:40am

annb0t

annb0t

Top 20
DXB Ann: DMX-700 Study Shows Significant 80% Reduction in Lung Injury
Price Sensitive: Y
Date: 4th Jul 2022, 8:40am

>>> Read announcement: Google: DXB Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
DXB Ann: DMX-200 FSGS PH3 Kidney Trial Part 1 Outcome set for Q1 CY24 - 24th Jul 2023, 8:32am
Replies
0
Views
69
annb0t
annb0t
annb0t
DXB Ann: DMX-200 FSGS Phase 3 Trial Part 1 Recruitment Achieved - 15th Dec 2022, 8:55am
Replies
0
Views
175
annb0t
annb0t
annb0t
DXB Ann: New Patent Family Application for DMX-700 - 9th Aug 2022, 8:48am
Replies
0
Views
175
annb0t
annb0t
annb0t
DXB Ann: New Clinical Trial for DMX-200 in Diabetic Kidney Disease - 7th Jun 2022, 8:59am
Replies
0
Views
190
annb0t
annb0t
annb0t
DXB Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS - 9th May 2022, 9:14am
Replies
0
Views
359
annb0t
annb0t
Top Bottom